CYTK Cytokinetics, Incorporated - Common Stock
$76.55
株価 · 8月 20, 2026
ファンダメンタルズ（時点） 8月 6, 2026
52週レンジ
$35–$88
78% of range
アナリスト評価
BUY
28 analysts
目標株価
$110
+44% upside
P/E (TTM)
-11.7
ROE
152.7%
純利益率
-891.6%
Cytokinetics, Incorporated - Common Stock について Wikipediaからの企業概要
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
続きを読む
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
History
Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.
Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based on cytoskeletal proteins. Eventually, the company narrowed its focus to the mechanics of muscle biology. Cytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases.
In 2004 the company completed its initial public offering (IPO).
In January 2007, Cytokinetics named Robert I. Blum as president and CEO. Prior to this, Blum has been involved in the company since its founding, with roles in business development, corporate development and R&D.
In 2013, Cytokinetics finalized a licensing and discovery deal with Astellas to research treatment for muscle weakness and fatigue.
In July 2020, Ji Xing Pharmaceuticals signed a financing deal with Cytokinetics, which included the rights to commercialize the drug designed to treat hypertrophic cardiomyopathies, aficamten, in China and certain neighboring regions.
Products
Omecamtiv mecarbil is a cardiac muscle activator for the potential treatment of heart failure. In May 2020, omecamtiv mecarbil was granted fast track designation by the FDA for the treatment of chronic HF with reduced ejection fraction. Amgen purchased an option on omecamtiv mecarbil in 2006, and the two companies extended their partnership several times. In June 2013, Cytokinetics and Amgen expanded their licensing deal for omecamtiv mecarbil to include Japan. In November 2020 Amgen elected to terminate the collaboration, effective May 20, 2021, and Cytokinetics regained worldwide rights to develop and commercialize omecamtiv mecarbil.
Reldesemtiv (previously known as CK-2127107) is a next-generation fast skeletal muscle troponin activator (FSTA) that has undergone clinical trials for ALS.
Aficamten (previously known as CK-3773274) is an oral, small-molecule myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM).
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
CYTK 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$76.55
時価総額
$9.41B
P/E (TTM)
-11.7
EPS（TTM）
$-6.54
収益（TTM）
$88M
配当利回り
—
ROE
152.7%
負債/自己資本
-0.4
52週レンジ
$35 – $88
CYTK 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$88M
2016-12-31
→
2025-12-31
EPS
$-6.54
2016-12-31
→
2025-12-31
フリーキャッシュフロー
$-535M
2016-12-31
→
2025-12-31
利益率
-891.6%
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
CYTK
競合中央値
P/E (TTM)
-11.7
28.5
P/S (TTM) (株価売上高倍率（TTM）)
106.9
20.1
P/B (株価純資産倍率)
-14.3
12.9
EV / EBITDA (EV/EBITDA)
-15.9
—
Price / FCF (株価FCF倍率)
-17.6
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
CYTK
競合中央値
Operating Margin (営業利益率)
-695.4%
—
Net Profit Margin (純利益率)
-891.6%
-48.4%
ROA
-55.5%
-28.4%
ROE
152.7%
-49.2%
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
CYTK
競合中央値
Debt / Equity (負債資本倍率)
-0.4
—
Current Ratio (流動比率)
4.5
5.0
Quick Ratio (クイックレシオ)
0.7
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
CYTK
競合中央値
Revenue YoY (収益（前年比）)
376.6%
—
Revenue CAGR 3Y (収益（3年CAGR）)
-2.4%
—
Revenue CAGR 5Y (収益（5年CAGR）)
9.5%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
CYTK
競合中央値
CYTK アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
28 アナリスト
- 強い買い 6 21.4%
- 買い 19 67.9%
- 保有 3 10.7%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
20 アナリスト · 2026-08-18
中央値
$107.50
← 全目標を下回る
$76.55
安値
$85.00
高値
$146.00
中央値ターゲット
$107.50
+40.4%
平均値ターゲット
$109.90
+43.6%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
-0.08%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $-1.50 | $-1.67 | 0.17% |
| 2026年3月31日 | $-1.67 | $-1.69 | 0.02% |
| 2025年12月31日 | $-1.50 | $-1.49 | -0.01% |
| 2025年9月30日 | $-2.55 | $-1.61 | -0.94% |
| 2025年6月30日 | $-1.12 | $-1.41 | 0.28% |
| 2025年3月31日 | $-1.39 | $-1.41 | 0.02% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| R&D Expense | $416M | $339M | $330M | $241M | $160M | $97M | $86M | $89M | $90M | $60M | $46M | $44M | |
| SG&A Expense | $284M | $215M | $174M | $178M | $97M | $53M | $40M | $31M | $36M | $28M | $20M | $17M | |
| Operating Expenses | $700M | $555M | $504M | $419M | $257M | $150M | $126M | $120M | $127M | $88M | $66M | $62M | |
| Operating Income | $-612M | $-536M | $-496M | $-324M | $-186M | $-94M | $-99M | $-89M | $-113M | $19M | $-37M | $-15M | |
| Interest Expense | $46M | $38M | $28M | $19M | $16M | $16M | $7M | $4M | $3M | $3M | $268.0K | $0 | |
| Interest Income | · | · | · | $11M | $1M | $5M | $4M | $4M | · | $449.0K | $156.0K | $101.0K | |
| Other Non-op | $48M | $52M | $28M | $11M | $331.0K | $5M | $5M | $4M | $3M | $464.0K | $174.0K | $108.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-106M | $-128M | $16M | $-38M | $-15M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| EPS (Basic) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.41 | $-0.97 | $-0.41 | |
| EPS (Diluted) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.39 | $-0.97 | $-0.41 | |
| Shares (Basic) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 39,943,000 | 38,814,000 | 35,709,000 | |
| Shares (Diluted) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 42,561,000 | 38,814,000 | 35,709,000 | |
| EBITDA | $-602M | $-527M | $-484M | $-318M | $-184M | $-92M | $-98M | $-88M | $-111M | $19M | $-37M | $-14M |
貸借対照表 26
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $123M | $95M | $113M | $66M | $113M | $83M | $36M | $42M | $125M | $67M | $65M | $20M | |
| Receivables | $18M | $17M | $1M | $147.0K | $52M | $4M | $5M | $2M | $1M | $24.0K | · | · | |
| Inventory | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $15M | $12M | $12M | $12M | $6M | $3M | $2M | $4M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $917M | $1.11B | $628M | $795M | $536M | $474M | $234M | $208M | $274M | $159M | $113M | $131M | |
| PP&E (Net) | $79M | $66M | $69M | $80M | $73M | $13M | $5M | $3M | $4M | $4M | $2M | $2M | |
| PP&E (Gross) | $126M | $103M | $97M | $98M | $89M | $38M | $29M | $27M | $26M | $25M | $23M | $22M | |
| Accum. Depreciation | $47M | $37M | $28M | $17M | $16M | $25M | $24M | $24M | $23M | $21M | $21M | $20M | |
| Other Non-current Assets | $17M | $8M | $8M | $10M | $7M | $6M | · | $300.0K | $429.0K | $200.0K | $200.0K | $200.0K | |
| Total Assets | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Accounts Payable | $22M | $20M | $22M | $26M | $21M | $8M | $8M | $4M | $5M | $4M | $2M | $1M | |
| Accrued Liabilities | $83M | $55M | $43M | $44M | $34M | $19M | $12M | $16M | $17M | $18M | $8M | $5M | |
| Current Liabilities | $202M | $180M | $103M | $85M | $72M | $31M | $26M | $22M | $32M | $33M | $32M | $24M | |
| Capital Leases | $108M | $113M | $120M | $127M | $112M | $440.0K | $2M | $771.0K | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $186.0K | $1M | $4M | $0 | · | $771.0K | $1M | $142.0K | · | · | |
| Total Liabilities | $2.08B | $1.54B | $1.21B | $1.12B | $597M | $420M | $301M | $185M | $185M | $76M | $47M | $41M | |
| Long-term Debt | $288M | $620M | $639M | $650M | · | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Total Debt | $288M | $105M | $68M | $64M | $47M | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Common Stock | $123.0K | $118.0K | $102.0K | $94.0K | $84.0K | $70.0K | $59.0K | $55.0K | $54.0K | $41.0K | $40.0K | $39.0K | |
| Paid-in Capital | · | · | · | · | $1.45B | · | · | · | · | · | · | $589M | |
| Retained Earnings | $-3.49B | $-2.70B | $-2.11B | $-1.59B | $-1.21B | $-992M | $-865M | $-743M | $-646M | $-518M | $-535M | $-497M | |
| AOCI | $630.0K | $2M | $-10.0K | $-4M | $-869.0K | $149.0K | $679.0K | $500.0K | $343.0K | $137.0K | $149.0K | $-4.0K | |
| Stockholders' Equity | $-660M | $-135M | $-386M | $-108M | $244M | $113M | $-11M | $26M | $110M | $94M | $69M | $92M | |
| Liabilities + Equity | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Shares Outstanding | 122,943,172 | 118,209,139 | 101,637,922 | 94,833,975 | 84,799,542 | 71,015,183 | 59,172,124 | 54,717,906 | 53,960,832 | 40,646,595 | 39,581,692 | 38,659,738 |
キャッシュフロー 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $10M | $12M | $6M | $2M | $2M | $1M | $1M | $2M | $741.0K | $589.0K | $490.0K | |
| Stock-based Comp | $112M | $98M | $72M | $48M | $27M | $18M | $11M | $10M | $9M | $7M | $5M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $153M | $86M | $28M | $36M | $44M | $117M | $19M | $-6M | $15M | $13M | $37M | $-34M | |
| Operating Cash Flow | $-510M | $-396M | $-414M | $-300M | $-143M | $9M | $-91M | $-101M | $-102M | $37M | $5M | $-45M | |
| CapEx | $25M | $4M | $1M | $11M | $49M | $11M | $3M | $889.0K | $3M | $2M | $562.0K | $1M | |
| Investing Cash Flow | $17M | $-553M | $239M | $-262M | $-148M | $-197M | $-75M | $5M | $-66M | · | · | · | |
| Net Debt Issued | $-11M | $-9M | · | $-48M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Net Stock Activity | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Financing Cash Flow | $524M | $931M | $221M | $516M | $320M | $234M | $160M | $13M | $226M | · | · | · | |
| Net Change in Cash | $30M | $-18M | $46M | $-45M | $30M | $47M | $-6M | $-83M | $58M | $2M | $45M | $57.0K | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-535M | $-400M | $-416M | $-311M | $-191M | $-2M | $-94M | $-102M | $-105M | $35M | $4M | $-46M | |
| Levered FCF | · | · | · | · | · | · | · | $-106M | $-108M | $33M | · | $-46M |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% | -130.5% | -31.4% | |
| Net Margin | -891.6% | -3191.1% | -6988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| Pretax Margin | · | · | · | · | · | · | · | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| EBITDA Margin | -683.9% | -2851.1% | -6431.8% | -336.6% | -261.3% | -165.0% | -363.2% | -278.3% | -833.9% | 18.3% | -128.5% | -30.4% | |
| ROA | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | |
| ROE | 152.7% | 789.8% | 127.6% | 628.0% | -87.4% | -96.8% | 790.0% | -272.5% | -125.2% | 20.2% | -46.7% | -20.0% | |
| ROIC | · | · | · | · | · | · | · | -130.1% | -80.1% | 15.0% | -44.9% | -16.0% |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 | 15.2 | 9.0 | 9.4 | 8.5 | 4.8 | 3.6 | 5.5 | |
| Quick Ratio | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 | 2.8 | 1.6 | 2.0 | 3.9 | 2.0 | 2.1 | 0.8 | |
| Debt / Equity | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.6 | 0.3 | 0.3 | 0.2 | · | |
| LT Debt / Equity | -0.4 | -0.7 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.5 | 0.3 | 0.3 | 0.2 | · | |
| Interest Coverage | -13.4 | -14.2 | -17.5 | -16.7 | -11.3 | -5.9 | -14.9 | -23.4 | -37.6 | 6.9 | · | · |
効率性 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.4 | |
| Receivables Turnover | 5.1 | 2.1 | 10.5 | 3.6 | 2.5 | 11.7 | 7.3 | 18.8 | 23.5 | · | · | · |
成長率 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 376.6% | 145.3% | -92.0% | 34.3% | 26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -36.0% | -48.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| Net Income TTM | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| Market Cap | $7.81B | $5.56B | $8.49B | $4.35B | $3.87B | $1.48B | $628M | $346M | $440M | $494M | $414M | $310M | |
| Enterprise Value | $7.98B | $5.57B | $8.44B | $4.34B | $3.80B | $1.44B | $636M | $346M | $346M | $457M | $364M | · | |
| P/E | -9.7 | -8.9 | -15.3 | -10.6 | -16.3 | -10.5 | · | · | -3.1 | 31.2 | -10.8 | -19.5 | |
| P/S | 88.7 | 301.0 | 1126.9 | 45.9 | 54.9 | 26.4 | 23.4 | 11.0 | 32.9 | 4.6 | 14.4 | 6.6 | |
| P/B | -11.8 | -41.1 | -22.0 | -40.3 | 15.8 | 13.0 | -57.4 | 13.3 | 4.0 | 5.2 | 6.0 | 3.4 | |
| P / Tangible Book | · | · | · | · | 15.8 | 13.0 | · | · | · | · | · | · | |
| P / Cash Flow | -15.3 | -14.0 | -20.5 | -14.5 | -27.1 | 165.0 | -6.9 | -3.4 | -4.3 | 13.4 | 84.8 | -6.9 | |
| P / FCF | -14.6 | -13.9 | -20.4 | -14.0 | -20.2 | -699.7 | -6.7 | -3.4 | -4.2 | 14.0 | 95.8 | -6.7 | |
| EV / EBITDA | -13.2 | -10.6 | -17.4 | -13.6 | -20.6 | -15.6 | -6.5 | -3.9 | -3.1 | 23.5 | -9.9 | · | |
| EV / FCF | -14.9 | -13.9 | -20.3 | -14.0 | -19.9 | -682.3 | -6.8 | -3.4 | -3.3 | 12.9 | 84.1 | · | |
| EV / Revenue | 90.6 | 301.5 | 1121.0 | 45.9 | 54.0 | 25.8 | 23.7 | 11.0 | 25.9 | 4.3 | 12.7 | · | |
| Earnings Yield | -10.3% | -11.2% | -6.5% | -9.4% | -6.1% | -9.5% | · | · | -31.8% | 3.2% | -9.3% | -5.1% |
損益計算書 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $19M | $18M | $2M | $67M | $2M | $17M | $463.0K | $249.0K | $835.0K | $2M | $378.0K | $867.0K | $5M | $2M | $3M | |
| R&D Expense | $98M | $96M | $104M | $99M | $110M | $98M | $94M | $85M | $80M | $82M | $85M | $83M | $83M | $79M | $75M | $63M | |
| SG&A Expense | $104M | $105M | $92M | $69M | $66M | $57M | $62M | $57M | $51M | $46M | $44M | $40M | $40M | $50M | $54M | $48M | |
| Operating Expenses | $208M | $203M | $196M | $169M | $178M | $157M | $156M | $141M | $130M | $127M | $129M | $123M | $123M | $129M | $129M | $111M | |
| Operating Income | $-179M | $-184M | $-178M | $-167M | $-112M | $-156M | $-139M | $-141M | $-130M | $-126M | $-127M | $-122M | $-122M | $-124M | $-127M | $-108M | |
| Interest Expense | · | · | $14M | $11M | $11M | · | $9M | $9M | $13M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Other Non-op | $14M | $11M | $11M | $10M | $13M | $14M | $15M | $17M | $12M | $8M | $8M | $7M | $7M | $6M | $6M | $4M | |
| Net Income | $-199M | $-206M | $-183M | $-306M | $-134M | $-161M | $-150M | $-161M | $-143M | $-136M | $-137M | $-129M | $-129M | $-131M | $-137M | $-142M | |
| EPS (Basic) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| EPS (Diluted) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| Shares (Basic) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| Shares (Diluted) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| EBITDA | $-179M | $-180M | · | $-167M | $-112M | $-153M | · | $-141M | $-130M | $-124M | · | $-122M | $-122M | $-123M | · | $-108M |
貸借対照表 24
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $255M | $130M | $123M | $225M | $75M | $74M | $95M | $47M | $190M | $120M | · | $100M | $69M | $102M | · | $106M | |
| Receivables | $24M | $7M | $18M | $2M | $8M | $2M | $17M | $244.0K | $0 | $834.0K | · | $2M | $985.0K | $1M | · | $2M | |
| Inventory | $380.0K | $154.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $18M | $14M | $17M | $13M | $20M | $16M | $15M | $7M | $11M | $19M | · | $20M | $20M | $16M | · | $14M | |
| Current Assets | $1.21B | $839M | $917M | $977M | $887M | $956M | $1.11B | $1.02B | $1.07B | $639M | · | $561M | $587M | $681M | · | $884M | |
| PP&E (Net) | $79M | $82M | $79M | $76M | $70M | $67M | $66M | $64M | $66M | $68M | · | $76M | $77M | $79M | · | $80M | |
| PP&E (Gross) | · | · | $126M | · | · | · | $103M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $37M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $19M | $18M | $17M | $17M | $15M | $13M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | · | |
| Total Assets | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Accounts Payable | $21M | $25M | $22M | $22M | $16M | $14M | $20M | $12M | $9M | $13M | · | $14M | $13M | $17M | · | $14M | |
| Accrued Liabilities | $77M | $69M | $83M | $62M | $52M | $43M | $55M | $50M | $40M | $40M | · | $33M | $31M | $36M | · | $40M | |
| Current Liabilities | $181M | $199M | $202M | $142M | $131M | $160M | $180M | $110M | $103M | $89M | · | $78M | $66M | $75M | · | $76M | |
| Capital Leases | $102M | $105M | $108M | $111M | $111M | $113M | $113M | $115M | $117M | $119M | · | $122M | $124M | $125M | · | $114M | |
| Other Non-current Liabilities | · | · | · | $2M | $2M | $3M | · | $0 | $0 | $2.0K | · | $408.0K | $625.0K | $837.0K | · | $1M | |
| Total Liabilities | $2.10B | $2.10B | $2.08B | $1.96B | $1.59B | $1.53B | $1.54B | $1.45B | $1.42B | $1.20B | · | $1.18B | $1.11B | $1.12B | · | $1.09B | |
| Long-term Debt | $276M | $292M | $288M | $1.00B | $610M | $610M | $105M | $620M | $629M | $630M | · | · | · | · | · | · | |
| Total Debt | $276M | $292M | · | $176M | $173M | $105M | · | $105M | $104M | $68M | · | $61M | $62M | $64M | · | $64M | |
| Common Stock | $138.0K | $124.0K | $123.0K | $122.0K | $119.0K | $119.0K | $118.0K | $118.0K | $117.0K | $105.0K | · | $94.0K | $94.0K | $94.0K | · | $93.0K | |
| Retained Earnings | $-3.89B | $-3.69B | $-3.49B | $-3.30B | $-3.00B | $-2.86B | $-2.70B | $-2.55B | $-2.39B | $-2.25B | · | $-1.98B | $-1.85B | $-1.72B | · | $-1.45B | |
| AOCI | $-4M | $-2M | $630.0K | $34.0K | $-158.0K | $2M | $2M | $5M | $-1M | $-539.0K | · | $-874.0K | $-1M | $-2M | · | $-6M | |
| Stockholders' Equity | $-173M | $-827M | $-660M | $-521M | $-369M | $-266M | $-135M | $-14M | $109M | $-396M | $-386M | $-439M | $-333M | $-229M | $-108M | $-16M | |
| Liabilities + Equity | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Shares Outstanding | · | · | 122,943,172 | · | · | · | 118,209,139 | · | · | · | · | · | · | · | · | · |
キャッシュフロー 12
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $36M | $30M | $31M | $31M | $28M | $24M | $26M | $25M | $25M | $22M | $19M | $19M | $19M | $15M | $13M | $13M | |
| Other Non-cash | · | $27M | · | · | · | $4M | · | · | · | $-18M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-160M | $-145M | $-143M | $-108M | $-128M | $-132M | $-66M | $-102M | $-99M | $-130M | $-74M | $-96M | $-122M | $-122M | $-98M | $-84M | |
| CapEx | $4M | $6M | $6M | $9M | $4M | $6M | $1M | $701.0K | $2M | $0 | $77.0K | $220.0K | $717.0K | $402.0K | $3M | $6M | |
| Investing Cash Flow | $-507M | $145M | $-71M | $-71M | $53M | $106M | $111M | $-45M | $-652M | $33M | $-81M | $73M | $82M | $165M | $29M | $-292M | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-705.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $0 | $0 | · | · | · | $94M | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $94M | · | · | · | · | · | · | |
| Financing Cash Flow | $793M | $8M | $111M | $330M | $79M | $5M | $2M | $3M | $821M | $104M | $169M | $54M | $5M | $-7M | $30M | $389M | |
| Net Change in Cash | $125M | $7M | $-103M | $152M | $2M | $-21M | $48M | $-143M | $70M | $7M | $13M | $31M | $-34M | $36M | $-39M | $13M | |
| Free Cash Flow | · | $-151M | · | · | · | $-137M | · | · | · | $-130M | · | · | · | $-123M | · | · |
収益性 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -626.0% | -948.7% | · | -8613.4% | -167.0% | -9856.3% | · | -30410.6% | -52277.9% | -15118.0% | · | -32345.2% | -14077.2% | -2698.3% | · | -4311.8% | |
| Net Margin | -694.4% | -1064.5% | · | -15815.0% | -201.3% | -10220.1% | · | -34675.0% | -57557.4% | -16244.7% | · | -34238.6% | -14837.0% | -2846.1% | · | -5658.4% | |
| EBITDA Margin | -626.0% | -931.2% | · | -8613.4% | -167.0% | -9710.6% | · | -30410.6% | -52277.9% | -14838.8% | · | -32345.2% | -14077.2% | -2658.2% | · | -4311.8% | |
| ROA | -12.6% | -16.2% | · | -21.3% | -9.8% | -15.6% | · | -14.8% | -12.4% | -16.0% | · | -14.2% | -16.6% | -15.0% | · | -14.9% | |
| ROE | 73.3% | 37.7% | · | 114.5% | 103.3% | 48.7% | · | 70.9% | 127.6% | 43.4% | · | 56.9% | 116.1% | 232.9% | · | -122.1% |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 4.2 | · | 6.9 | 6.8 | 6.0 | · | 9.3 | 10.4 | 7.2 | · | 7.2 | 8.9 | 9.0 | · | 11.6 | |
| Quick Ratio | 1.5 | 0.7 | · | 1.6 | 0.6 | 0.5 | · | 0.4 | 1.9 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.4 | |
| Debt / Equity | -1.6 | -0.4 | · | -0.3 | -0.5 | -0.4 | · | -7.5 | 1.0 | -0.2 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| LT Debt / Equity | -1.4 | -0.3 | · | -0.3 | -0.4 | -0.3 | · | -6.7 | 0.9 | -0.1 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| Interest Coverage | · | · | · | -14.7 | -10.1 | · | · | -15.8 | -10.2 | -17.8 | · | -17.1 | -17.3 | -17.9 | · | -15.9 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.7 | 4.4 | · | 1.9 | 15.9 | 1.1 | · | 0.3 | 0.5 | 0.9 | · | 0.2 | 0.6 | 1.3 | · | 1.7 |
バリュエーション（TTM） 4
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $90M | · | $71M | $69M | $3M | · | $2M | $2M | $7M | · | $8M | $97M | $97M | · | $98M | |
| Net Income TTM | $-845M | $-808M | · | $-762M | $-600M | $-601M | · | $-569M | $-537M | $-525M | · | $-532M | $-422M | $-383M | · | $-328M | |
| P/E | -12.5 | -9.8 | · | -8.6 | -6.4 | -7.5 | · | -9.9 | -10.2 | -13.0 | · | -5.3 | -7.3 | -8.4 | · | -12.9 | |
| Earnings Yield | -8.0% | -10.2% | · | -11.6% | -15.6% | -13.3% | · | -10.1% | -9.8% | -7.7% | · | -19.0% | -13.7% | -11.9% | · | -7.7% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $88M | $18M | $8M | $95M | $70M |
| 営業利益率 % | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% |
| 純利益 | $-785M | $-590M | $-526M | $-389M | $-215M |
| 希薄化後EPS | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 |
| 流動比率 | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 |
| クイックレシオ | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $-535M | $-400M | $-416M | $-311M | $-191M |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 539 提出者 · $9.0B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 95 (-9 前期比) | 49 (-6 前期比) | 230 (+51 前期比) | 112 (-32 前期比) | +5.3M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $571,778,157 | 6,711,799 | 6.37% | 株式数 |
| STATE STREET CORP | $553,243,709 | 6,494,233 | 6.16% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $521,151,103 | 6,117,515 | 5.80% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $509,521,049 | 5,980,996 | 5.67% | 株式数 |
| Avoro Capital Advisors LLC | $425,949,915 | 4,999,999 | 4.74% | 株式数 |
| FMR LLC | $375,035,430 | 4,402,341 | 4.18% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $259,207,450 | 3,042,018 | 2.89% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $251,706,463 | 2,954,648 | 2.80% | 株式数 |
| RTW INVESTMENTS, LP | $243,814,036 | 2,862,003 | 2.72% | 株式数 |
| Polar Capital Holdings Plc | $191,988,358 | 2,253,649 | 2.14% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161,060,214 | 1,890,600 | 1.79% | コールオプション |
| Capital Research Global Investors | $143,683,584 | 1,686,625 | 1.60% | 株式数 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $136,597,224 | 1,603,442 | 1.52% | 株式数 |
| Integral Health Asset Management, LLC | $136,304,000 | 1,600,000 | 1.52% | 株式数 |
| Point72 Asset Management, L.P. | $135,257,185 | 1,587,712 | 1.51% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $133,386,924 | 1,565,758 | 1.49% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $131,998,327 | 1,549,458 | 1.47% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $111,435,932 | 1,308,087 | 1.24% | 株式数 |
| Capital International Investors | $111,245,191 | 1,305,848 | 1.24% | 株式数 |
| ARMISTICE CAPITAL, LLC | $106,487,500 | 1,250,000 | 1.19% | コールオプション |
| ARMISTICE CAPITAL, LLC | $102,342,325 | 1,201,342 | 1.14% | 株式数 |
| Pictet Asset Management Holding SA | $99,038,455 | 1,160,463 | 1.10% | 株式数 |
| Frazier Life Sciences Management, L.P. | $98,810,092 | 1,159,879 | 1.10% | 株式数 |
| Holocene Advisors, LP | $97,506,685 | 1,144,579 | 1.09% | 株式数 |
| Woodline Partners LP | $93,769,315 | 1,100,708 | 1.04% | 株式数 |
| NORGES BANK | $86,512,319 | 1,015,522 | 0.96% | 株式数 |
| Royalty Pharma Sub-Manager, LLC | $83,519,594 | 980,392 | 0.93% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $81,937,000 | 961,815 | 0.91% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $77,218,175 | 906,423 | 0.86% | 株式数 |
| CITADEL ADVISORS LLC | $77,062,874 | 904,600 | 0.86% | コールオプション |
| Melqart Asset Management (UK) Ltd | $65,385,455 | 767,525 | 0.73% | 株式数 |
| Siren, L.L.C. | $64,655,121 | 758,952 | 0.72% | 株式数 |
| Fisher Asset Management, LLC | $63,355,547 | 743,697 | 0.71% | 株式数 |
| Foresite Capital Management IV, LLC | $60,884,867 | 714,695 | 0.68% | 株式数 |
| Balyasny Asset Management L.P. | $60,599,821 | 711,349 | 0.67% | 株式数 |
| Deep Track Capital, LP | $59,633,000 | 700,000 | 0.66% | 株式数 |
| JANE STREET GROUP, LLC | $59,633,000 | 700,000 | 0.66% | コールオプション |
| BNP PARIBAS FINANCIAL MARKETS | $58,702,470 | 689,077 | 0.65% | 株式数 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $56,251,809 | 660,310 | 0.63% | 株式数 |
| CITADEL ADVISORS LLC | $54,601,338 | 640,936 | 0.61% | 株式数 |
| GOLDMAN SACHS GROUP INC | $54,053,311 | 634,503 | 0.60% | 株式数 |
| Qube Research & Technologies Ltd | $48,774,257 | 572,535 | 0.54% | 株式数 |
| EVENTIDE ASSET MANAGEMENT, LLC | $48,081,832 | 564,398 | 0.54% | 株式数 |
| Affinity Asset Advisors, LLC | $46,854,500 | 550,000 | 0.52% | 株式数 |
| First Turn Management, LLC | $44,930,228 | 527,412 | 0.50% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $44,162,525 | 518,398 | 0.49% | 株式数 |
| Caption Management, LLC | $43,651,356 | 512,400 | 0.49% | コールオプション |
| D. E. Shaw & Co., Inc. | $40,874,247 | 479,801 | 0.46% | 株式数 |
| Checkpoint Capital L.P. | $40,465,250 | 475,000 | 0.45% | 株式数 |
| Hood River Capital Management LLC | $39,977,367 | 469,273 | 0.45% | 株式数 |
| RP Management, LLC | $39,401,954 | 980,392 | 0.44% | 株式数 |
| EMERALD ADVISERS, LLC | $39,013,272 | 457,956 | 0.43% | 株式数 |
| ADAR1 Capital Management, LLC | $39,009,097 | 457,907 | 0.43% | 株式数 |
| AMERIPRISE FINANCIAL INC | $38,010,006 | 446,179 | 0.42% | 株式数 |
| Candriam S.C.A. | $37,708,477 | 443,066 | 0.42% | 株式数 |
| MARSHALL WACE, LLP | $36,259,335 | 425,629 | 0.40% | 株式数 |
| RHUMBLINE ADVISERS | $35,933,015 | 421,799 | 0.40% | 株式数 |
| CITADEL ADVISORS LLC | $35,882,028 | 421,200 | 0.40% | プットオプション |
| ALLIANCEBERNSTEIN L.P. | $35,327,299 | 535,993 | 0.39% | 株式数 |
| GILDER GAGNON HOWE & CO LLC | $34,096,829 | 400,245 | 0.38% | 株式数 |
| TD Asset Management Inc | $32,809,225 | 385,130 | 0.37% | 株式数 |
| BlackRock, Inc. | $29,124,928 | 341,882 | 0.32% | 株式数 |
| GSK plc | $29,001,573 | 340,434 | 0.32% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $27,040,243 | 317,411 | 0.30% | 株式数 |
| CITIGROUP INC | $26,852,314 | 315,205 | 0.30% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24,671,024 | 289,600 | 0.27% | プットオプション |
| Trails Edge Capital Partners, LP | $24,542,302 | 288,089 | 0.27% | 株式数 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $23,833,521 | 279,769 | 0.27% | 株式数 |
| Polaris Capital Management, LLC | $22,737,211 | 266,900 | 0.25% | 株式数 |
| SEGALL BRYANT & HAMILL, LLC | $21,899,197 | 257,063 | 0.24% | 株式数 |
| Alyeska Investment Group, L.P. | $21,297,500 | 250,000 | 0.24% | 株式数 |
| ExodusPoint Capital Management, LP | $21,234,374 | 249,259 | 0.24% | 株式数 |
| Capital World Investors | $21,196,550 | 248,815 | 0.24% | 株式数 |
| Walleye Capital LLC | $20,422,428 | 239,728 | 0.23% | 株式数 |
| E. Ohman J:or Asset Management AB | $19,823,223 | 300,762 | 0.22% | 株式数 |
| Sarissa Capital Management LP | $19,476,393 | 228,623 | 0.22% | 株式数 |
| Swiss National Bank | $18,946,256 | 222,400 | 0.21% | 株式数 |
| SPHERA FUNDS MANAGEMENT LTD. | $18,740,693 | 219,987 | 0.21% | 株式数 |
| BAKER BROS. ADVISORS LP | $17,997,836 | 211,267 | 0.20% | 株式数 |
| California Public Employees Retirement System | $17,979,520 | 211,052 | 0.20% | 株式数 |
| Nicholas Investment Partners, LP | $17,810,758 | 209,071 | 0.20% | 株式数 |
| PINNACLE ASSOCIATES LTD | $17,245,864 | 202,440 | 0.19% | 株式数 |
| Mirador Capital Partners LP | $17,239,900 | 202,370 | 0.19% | 株式数 |
| Tri Locum Partners LP | $16,526,860 | 194,000 | 0.18% | 株式数 |
| PFM Health Sciences, LP | $16,329,730 | 191,686 | 0.18% | 株式数 |
| Rock Springs Capital Management LP | $16,014,016 | 187,980 | 0.18% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $15,933,512 | 187,035 | 0.18% | 株式数 |
| DAFNA Capital Management LLC | $14,652,510 | 171,998 | 0.16% | 株式数 |
| Ghisallo Capital Management LLC | $14,482,300 | 170,000 | 0.16% | 株式数 |
| Impax Asset Management Group plc | $14,056,350 | 165,000 | 0.16% | 株式数 |
| Lombard Odier Asset Management (Europe) Ltd | $13,494,096 | 158,400 | 0.15% | コールオプション |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $13,383,349 | 157,100 | 0.15% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13,330,276 | 156,477 | 0.15% | 株式数 |
| JANE STREET GROUP, LLC | $12,735,905 | 149,500 | 0.14% | プットオプション |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $12,145,719 | 139,190 | 0.14% | 株式数 |
| Retirement Systems of Alabama | $11,962,891 | 140,426 | 0.13% | 株式数 |
| MetLife Investment Management, LLC | $11,930,519 | 140,046 | 0.13% | 株式数 |
| Polymer Capital Management (HK) LTD | $11,777,943 | 138,255 | 0.13% | 株式数 |
| Cinctive Capital Management LP | $11,742,419 | 137,838 | 0.13% | 株式数 |
| TUDOR INVESTMENT CORP ET AL | $11,279,156 | 132,400 | 0.13% | コールオプション |
企業インサイダー 52 人のインサイダー · 18人の役員 · 22人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Sung Lee | EVP, Chief Financial Officer | 2026年7月1日 M | 63,221 | 0 | 5 | $-5,695,855 |
| Ching Jaw | SVP Finance & CFO | 2023年3月6日 A | 87,346 | 0 | 0 | $0 |
| Sharon Surrey Barbari | EVP, Finance & CFO | 2017年2月28日 F | 40,323 | 0 | 0 | $0 |
| Fady Ibraham Malik | EVP Research & Development | 2026年8月18日 M | 153,902 | 0 | 21 | $-4,352,750 |
| Andrew Callos | EVP, Chief Commercial Officer | 2026年7月30日 M | 58,555 | 0 | 24 | $-15,318,893 |
| Jeffrey Hessekiel | Chief Legal & Admin Officer | 2026年3月15日 A | 107,943 | 0 | 0 | $0 |
| Robert Wong | VP, Chief Accounting Officer | 2024年12月3日 A | 18,655 | 0 | 0 | $0 |
| Brett A Pletcher | EVP, Chief Legal Officer | 2024年8月30日 A | 33,140 | 0 | 0 | $0 |
| Mark A Schlossberg | SVP - Legal & General Counsel | 2022年3月15日 M | 103,408 | 0 | 0 | $0 |
| David Cragg | Chief HR & Admin Officer | 2022年3月7日 F | 153,233 | 0 | 0 | $0 |
| Caryn Gordon Mcdowell | GC & Chief Compliance Officer | 2018年2月27日 A | 32,548 | 0 | 0 | $0 |
| Peter S Roddy | SVP Finance & CAO | 2018年2月27日 A | 21,520 | 0 | 0 | $0 |
| Bradley Paul Morgan | SVP Drug Discovery & Early Dev | 2017年8月31日 M | 46,441 | 0 | 0 | $0 |
| Bonnie Charpentier | SVP Regulatory & Compliance | 2017年2月28日 A | 29,004 | 0 | 0 | $0 |
| Andrew A Wolff | SVP & CMO | 2017年2月28日 A | 47,255 | 0 | 0 | $0 |
| David J Morgans JR | EVP-Preclinical R&D | 2011年2月28日 A | 42,000 | 0 | 0 | $0 |
| Michael Rabson | SVP Business Dev/Legal & GC | 2009年12月18日 M | 20,043 | 0 | 0 | $0 |
| Jay K Trautman | VP, Discovery Research | 2008年2月29日 A | 47,896 | 0 | 0 | $0 |
| Robert Arthur Harrington | 取締役 | 2026年7月15日 A | 21,932 | 0 | 2 | $-248,260 |
| James M Daly | 取締役 | 2026年7月15日 A | 3,390 | 0 | 0 | $0 |
| Edward M. Kaye MD | 取締役 | 2026年7月15日 A | 10,434 | 0 | 6 | $-3,544,372 |
| Nancy Wysenski | 取締役 | 2026年7月15日 A | 33,992 | 0 | 0 | $0 |
| Wendell Wierenga | 取締役 | 2026年7月15日 A | 35,563 | 0 | 3 | $-1,881,925 |
| John T Henderson | 取締役 | 2026年7月15日 A | 78,360 | 0 | 2 | $-2,078,525 |
| Lynne B Parshall | 取締役 | 2026年6月1日 S | 15,784 | 0 | 3 | $-1,000,100 |
| Muna Bhanji | 取締役 | 2026年5月27日 A | 26,361 | 0 | 0 | $0 |
| Robert E Landry | 取締役 | 2026年5月27日 A | 10,184 | 0 | 0 | $0 |
| Wendall Wierenga | 取締役 | 2025年7月15日 A | 32,345 | 0 | 0 | $0 |
| COSTA SANTO J | 取締役 | 2024年5月15日 A | 20,600 | 0 | 0 | $0 |
| Sandford D Smith | 取締役 | 2024年1月2日 A | 18,801 | 0 | 0 | $0 |
| Robert Califf | 取締役 | 2022年1月3日 A | 6,003 | 0 | 0 | $0 |
| GAGE L PATRICK | 取締役 | 2021年11月8日 M | 28,932 | 0 | 0 | $0 |
| Denise Gilbert | 取締役 | 2015年5月20日 J | — | 0 | 0 | $0 |
| Stephen M Dow | 取締役 | 2013年1月2日 A | 1,421,052 | 0 | 0 | $0 |
| James A Spudich | 取締役 | 2011年5月18日 A | 180,600 | 0 | 0 | $0 |
| Grant A Heidrich III | 取締役 | 2011年1月3日 A | 93,755 | 0 | 0 | $0 |
| Michael Schmertzler | 取締役 | 2010年6月3日 S | 4,340,923 | 0 | 0 | $0 |
| Mark Mcdade | 取締役 | 2009年5月21日 A | — | 0 | 0 | $0 |
| Charles J Homcy | 取締役 | 2008年5月22日 A | — | 0 | 0 | $0 |
| William J Rutter | 取締役 | 2004年4月29日 C | 172,413 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VI LP | 10%オーナー | 2004年4月29日 C | 1,615,716 | 0 | 0 | $0 |
| SRB ASSOCIATES VIII LP | 10%オーナー | 2004年4月29日 C | 771,052 | 0 | 0 | $0 |
| SRB ASSOCIATES VII LP | 10%オーナー | 2004年4月29日 C | 650,000 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VIII LP | 10%オーナー | 2004年4月29日 C | 755,631 | 0 | 0 | $0 |
| Robert I Blum | — | 2026年8月10日 M | 377,820 | 0 | 19 | $-9,702,097 |
| Elisabeth Schnieders | — | 2017年2月28日 A | 43,919 | 0 | 0 | $0 |
| James H Sabry | — | 2010年6月3日 M | 0 | 0 | 0 | $0 |
| SEVIN ROSEN VII AFFILIATES FUND LP | — | 2004年4月29日 C | 24,050 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VII LP | — | 2004年4月29日 C | 625,950 | 0 | 0 | $0 |
| SRB ASSOCIATES VI LP | — | 2004年4月29日 C | 1,742,951 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
ETF保有状況 84のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3.16% | 43,268 NS | 2026年5月31日 | N-PORT |
| HRTS · Tema ETF Trust | 2.52% | 17,069 NS | 2026年5月31日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.78% | 61,402 SH | 2026年8月19日 | 日次 |
| FMED · Fidelity Covington Trust | 1.55% | 8,262 NS | 2026年5月31日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1.40% | 3,663 NS | 2026年5月31日 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.24% | 189,801 NS | 2026年4月30日 | N-PORT |
| JSML · Janus Detroit Street Trust | 0.98% | 48,338 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 76,297 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.75% | 4,355 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.68% | 7,501 SH | 2026年8月19日 | 日次 |
| IBB · iShares Trust | 0.66% | 884,741 SH | 2026年8月19日 | 日次 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.64% | 102,933 SH | 2026年8月19日 | 日次 |
| IWN · iShares Trust | 0.57% | 1,104,827 SH | 2026年8月19日 | 日次 |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 41,612 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.47% | 4,553 NS | 2026年5月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.47% | 94,565 NS | 2026年4月30日 | N-PORT |
| MIDE · DBX ETF Trust | 0.41% | 178 NS | 2026年5月29日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.37% | 22,056 SH | 2026年8月19日 | 日次 |
| IQSM · New York Life Investments ETF Trust | 0.34% | 16,959 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.34% | 761,130 SH | 2026年8月19日 | 日次 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.33% | 72,343 SH | 2026年8月19日 | 日次 |
| VBK · VANGUARD INDEX FUNDS | 0.32% | 1,797,986 SH | 2026年8月19日 | 日次 |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.32% | 219,413 SH | 2026年8月19日 | 日次 |
| IWM · iShares Trust | 0.31% | 3,379,531 SH | 2026年8月19日 | 日次 |
| IVOV · VANGUARD ADMIRAL FUNDS | 0.31% | 53,623 SH | 2026年8月19日 | 日次 |
| ISCG · iShares Trust | 0.29% | 38,968 SH | 2026年8月19日 | 日次 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.26% | 55,086 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.25% | 6,062 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.23% | 51,834 NS | 2026年4月30日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.23% | 14,028 NS | 2026年4月30日 | N-PORT |
| MVV · ProShares Trust | 0.22% | 4,565 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.21% | 635,330 NS | 2026年5月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.20% | 19,862 NS | 2026年4月30日 | N-PORT |
| ESML · iShares Trust | 0.19% | 72,366 SH | 2026年8月19日 | 日次 |
| SCHM · SCHWAB STRATEGIC TRUST | 0.19% | 356,940 NS | 2026年5月31日 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.19% | 37,821 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 40,586 SH | 2026年8月19日 | 日次 |
| MIDU · Direxion Shares ETF Trust | 0.15% | 2,025 NS | 2026年4月30日 | N-PORT |
| UMDD · ProShares Trust | 0.15% | 638 NS | 2026年5月31日 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 11,444 NS | 2026年4月30日 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 47,609 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.15% | 4,765 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.15% | 5,565 SH | 2026年8月19日 | 日次 |
| SMDX · Tidal Trust III | 0.15% | 2,868 NS | 2026年4月30日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.14% | 3,113,794 SH | 2026年8月19日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.14% | 333,056 SH | 2026年8月19日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.13% | 1,557,779 SH | 2026年8月19日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 53,720 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.12% | 154 NS | 2026年5月31日 | N-PORT |
| NBCR · Neuberger Berman ETF Trust | 0.10% | 12,090 NS | 2026年5月31日 | N-PORT |